Search
for
Sort by
Research 271–300 of 788
- Janus kinase inhibitors for alopecia areata
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Hair regrowth in a patient with alopecia universalis and psoriasis vulgaris during deucravacitinib therapy
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Combination of baricitinib and conventional immunomodulating therapy for alopecia totalis
- Alopecia Areata of the Nails: Diagnosis and Management
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Review of Promising Off-Label Use of Deucravacitinib
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Ruxolitinib found to cause eyelash growth: a case report
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Case Report: A novel KRT74 variant in an eight-year-old boy with alopecia totalis successfully treated with baricitinib
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Referee report. For: Molecular mediators involved in skin healing: a narrative review [version 1; peer review: 1 approved with reservations]
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1